An increased risk of chronic pancreatitis has been described among carriers of the cystic fibrosis transmembrane regulator (CFTR) mutation. In addition, patients with cystic fibrosis may have a higher risk of exocrine pancreatic cancer.
Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group.
Grup de Recerca d'Epidemiologia Clínica i Molecular del Càncer, Institut Municipal d'Investigació Mèdica, Universitat Pompeu Fabra, Barcelona, Universitat Autònoma de Barcelona, Spain. nuria@imim.es